- Home
- AUPH vs MCRI Comparison
AUPH vs MCRI Comparison
Compare AUPH & MCRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | MCRI |
|---|---|---|
| Founded | 1993 | 1972 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | AUPH | MCRI |
|---|---|---|
| Price | $14.93 | $122.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $17.25 | ★ $111.50 |
| AVG Volume (30 Days) | ★ 1.2M | 129.9K |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 1.00% |
| EPS Growth | ★ 5075.00 | 41.41 |
| EPS | 0.25 | ★ 1.52 |
| Revenue | $283,055,000.00 | ★ $395,377,000.00 |
| Revenue This Year | $17.54 | $4.85 |
| Revenue Next Year | $15.74 | $2.21 |
| P/E Ratio | ★ $60.02 | $80.24 |
| Revenue Growth | 20.38 | ★ 114.40 |
| 52 Week Low | $10.34 | $88.13 |
| 52 Week High | $19.25 | $135.93 |
Technical Indicators
Market Signals| Indicator | AUPH | MCRI |
|---|---|---|
| Relative Strength Index (RSI) | 37.04 | 45.34 |
| Support Level | $14.60 | $112.85 |
| Resistance Level | $15.23 | $128.35 |
| Average True Range (ATR) | 0.49 | 3.23 |
| MACD | -0.10 | -0.14 |
| Stochastic Oscillator | 17.08 | 62.32 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.